Thought Leadership

Top 10 Challenges in Biopharma Competitive Intelligence – How to Face Them Head-On

Prescient has conducted research among competitive intelligence (CI) stakeholders throughout the biopharmaceutical industry to identify the top challenges in CI and to highlight the strategic imperatives and actionable recommendations to face these challenges head-on. We developed a white paper to summarize the research and provide our insights and expertise.

Read More

Case Studies

case study
Strategic Brand Planning: Winning by Resource Optimization

Our client was a global biopharmaceutical company with a market-leading brand more than 20 years’ old. It came under intense pricing pressure due to generic entries from companies known to play primarily on price. The company faced issues in identifying key investment areas to help maintain the brand’s market leader position. Prescient was engaged to […]

case study
Mature Brand Planning: Specialty Product Late Life Cycle Management Strategy

Our global pharmaceutical client had a product whose patent was expiring within a year. The client wanted to understand the potential impact of generic competition on its brand in key revenue markets. Prescient was engaged to develop tactics to defend market share in these markets by: Identifying key generic competitors and anticipating their global strategies […]

case study
Net Present Value: Assessing Opportunities for Indication Expansion

Our client, a European specialty pharmaceutical company, was considering an expansion of indications within its target therapeutic group via licensing and acquiring products that were in clinical development, soon-to-be-launched or already marketed. The client engaged Prescient to prepare a comprehensive commercial valuation of a late-stage licensing opportunity to support the assessment of a go/no-go decision […]